HYPOPHOSPHATASIA (HPP)

Clinical trials for HYPOPHOSPHATASIA (HPP) explained in plain language.

Never miss a new study

Get alerted when new HYPOPHOSPHATASIA (HPP) trials appear

Sign up with your email to follow new studies for HYPOPHOSPHATASIA (HPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First pill for rare bone disease enters human testing

Disease control Recruiting now

This is the first study in people of an oral drug called ALE1 for hypophosphatasia (HPP), a rare genetic bone disorder. It aims to find out if the pill is safe, how the body processes it, and how it affects key biomarkers. The study will include about 120 healthy adults and adult…

Matched conditions: HYPOPHOSPHATASIA (HPP)

Phase: PHASE1, PHASE2 • Sponsor: Alesta Therapeutics • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

HYPOPHOSPHATASIA (HPP)

Get alerted when new HYPOPHOSPHATASIA (HPP) trials appear

First pill for rare bone disease enters human testing